drugset / Trial / NCT03580590

Efficacy of Oral Diltiazem on the Intraoperative Bleeding in Functional Endoscopic Sinus Surgery

NCT03580590

Phase 0 Unknown 40 enrolled Assiut University
RandomizedParallel-groupDouble-blindPrevention

Summary

* The primary endpoint is the effect of the addition of oral Diltiazem and Tranexamic Acid to general anesthesia aided reduction in blood loss during functional endoscopic sinus surgery (FESS). * The secondary endpoint is surgeon's assessment of the surgical field and hemodynamics.

Timeline

Start
2018-09-01
Primary completion
2019-11-01
Completion
2020-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Diltiazem Small molecule 90 mg Oral
Subject Tranexamic Acid Small molecule 10 mg/kg Intravenous